Suboptimal Weight Affects Survival in Cervical Cancer
|
By HospiMedica International staff writers Posted on 05 May 2016 |
Both overweight and underweight women with cervical cancer did not live as long as their normal-weight counterparts, according to a new study.
Researchers at the University of Cincinnati (OH, USA) and the University of North Carolina (UNC; Chapel Hill, USA) conducted a retrospective cohort study of 623 women with cervical cancer treated from July 2000 to March 2013, classifying the women according to their body mass index (BMI). In all, 4% of the women were underweight, 30% were normal weight, and 66% were overweight or obese. The primary outcome was overall survival; secondary outcomes included stage, histopathology, disease-specific survival (DSS), and recurrence free survival (RFS).
The results showed that the median overall survival time in overweight or obese women was six months shorter than in women of normal weight (22 versus 28 months); for underweight women, median overall survival time was cut in half (14 versus 28 months). There was no difference in age, stage at presentation, grade, or histology between weight categories. After controlling for prognostic factors, underweight and overweight/obese patients had worse median RFS than normal weight patients. The study was published on April 14, 2016, in in Gynecologic Oncology.
“In understanding the effect of BMI on cervical cancer outcomes, it is important to recognize that both extremes of weight appear to negatively impact survival. A potential unifying hypothesis connecting both extremes of weight to poor cancer prognosis is chronic systemic inflammation,” wrote lead author Leslie Clark, MD, of UNC, and colleagues. “Both patients with cancer cachexia/sarcopenia and overweight/obese patients are in a heightened inflammatory state, which may lead to increased cell proliferation and inhibition of apoptosis.”
"However, this is likely not the only mechanism of poor outcomes. Co-morbid medical conditions might account for some of the differences in survival, particularly in morbidly obese patients,” concluded the authors. “Providers should optimize weight in underweight and overweight/obese patients to attempt to improve outcomes in these women. Interventions that target nutritional counseling and physical activity should be explored in these populations.”
Related Links:
University of Cincinnati
University of North Carolina
Researchers at the University of Cincinnati (OH, USA) and the University of North Carolina (UNC; Chapel Hill, USA) conducted a retrospective cohort study of 623 women with cervical cancer treated from July 2000 to March 2013, classifying the women according to their body mass index (BMI). In all, 4% of the women were underweight, 30% were normal weight, and 66% were overweight or obese. The primary outcome was overall survival; secondary outcomes included stage, histopathology, disease-specific survival (DSS), and recurrence free survival (RFS).
The results showed that the median overall survival time in overweight or obese women was six months shorter than in women of normal weight (22 versus 28 months); for underweight women, median overall survival time was cut in half (14 versus 28 months). There was no difference in age, stage at presentation, grade, or histology between weight categories. After controlling for prognostic factors, underweight and overweight/obese patients had worse median RFS than normal weight patients. The study was published on April 14, 2016, in in Gynecologic Oncology.
“In understanding the effect of BMI on cervical cancer outcomes, it is important to recognize that both extremes of weight appear to negatively impact survival. A potential unifying hypothesis connecting both extremes of weight to poor cancer prognosis is chronic systemic inflammation,” wrote lead author Leslie Clark, MD, of UNC, and colleagues. “Both patients with cancer cachexia/sarcopenia and overweight/obese patients are in a heightened inflammatory state, which may lead to increased cell proliferation and inhibition of apoptosis.”
"However, this is likely not the only mechanism of poor outcomes. Co-morbid medical conditions might account for some of the differences in survival, particularly in morbidly obese patients,” concluded the authors. “Providers should optimize weight in underweight and overweight/obese patients to attempt to improve outcomes in these women. Interventions that target nutritional counseling and physical activity should be explored in these populations.”
Related Links:
University of Cincinnati
University of North Carolina
Latest Patient Care News
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
Channels
Artificial Intelligence
view channel
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read moreFacial Image Analysis Tracks Biological Aging, Predicts Cancer Outcomes
Biological aging is the progressive loss of physiological function that may diverge from chronological age. In cancer care, clinicians need simple tools that reflect dynamic changes in patient resilience... Read moreCritical Care
view channel
New Nasal Spray Enables Prehospital Neuroprotection in Ischemic Stroke
Ischemic stroke, caused by arterial occlusion in the brain, requires time‑critical intervention to limit neuronal loss. Many patients arrive outside the narrow window for thrombolysis or thrombectomy,... Read more
Single-Lead AI ECG Tool Detects Moderate-to-Severe Hyperkalemia Outside Clinic
Hyperkalemia can escalate quickly and is commonly monitored through laboratory blood draws, leaving risk between clinic visits. Clinicians need timely, accessible tools to identify moderate to severe elevations... Read moreSurgical Techniques
view channel
New Endoscopic Device Offers Minimally Invasive Approach to Obesity Management
Obesity is increasing worldwide, and many patients face a gap between lifestyle interventions, pharmacotherapy, and bariatric surgery. Endoscopic approaches are emerging as additional treatment options... Read more
Robotic Microsurgery System Gains CE Mark for Clinical Use in Europe
Microsure (Eindhoven, The Netherlands) announced on May 7, 2026 that its MUSA-3 system received CE mark approval, enabling clinical use in Europe. The milestone marks the company’s transition from product... Read moreHealth IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read moreBusiness
view channel
Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
Olympus has signed an exclusive global distribution agreement with EndoRobotics Co., Ltd., under which robot-assisted technologies developed by EndoRobotics will be distributed worldwide as part of the... Read more







